Novartis Investigative Site

Pottstown, Pennsylvania 19464

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerosis, Chronic Obstructive Pulmonary Disease, Neoplasms, Breast

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed